CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Treatment outcomes of high-dose chemotherapy plus stem cell rescue in high-risk neuroblastoma patients in Thailand
Kunanya Suwannaying, Piti Techavichit, Patcharee Komvilaisak, Napat Laoaroon, Nattee Narkbunnam, Kleebsabai Sanpakit, Kanhatai Chiengthong, Thirachit Chotsampancharoen, Lalita Sathitsamitphong, Chalongpon Santong, Panya Seksarn, Suradej Hongeng, Surapon Wiangnon
Clin Exp Pediatr. 2022;65(9):453-458.   Published online May 24, 2022
DOI: https://doi.org/10.3345/cep.2022.00437

Excel Download

Treatment outcomes of high-dose chemotherapy plus stem cell rescue in high-risk neuroblastoma patients in Thailand
Clinical and Experimental Pediatrics. 2022;65(9):453-458   Crossref logo
Link1 Link2 Link3

Treatment of poor-risk neuroblastoma patients with high-dose chemotherapy and autologous peripheral stem cell rescue
Bone Marrow Transplantation. 1997;20(7):543-551   Crossref logo
Link1 Link2 Link3

Gonadal Failure Is Common in Long-Term Survivors of Childhood High-Risk Neuroblastoma Treated With High-Dose Chemotherapy and Autologous Stem Cell Rescue
Frontiers in Endocrinology. 2019;10:   Crossref logo
Link1

High-Dose Chemotherapy with Busulfex and Melphalan As Conditioning Regimen Followed By Autologous STEM CELL Rescue for Pediatric Patients with High-Risk Neuroblastoma
Biology of Blood and Marrow Transplantation. 2014;20(2):S166   Crossref logo
Link1 Link2

Initial high dose chemotherapy plus autologous stem cell support improves survival outcomes compared with a standard CHOP regimen in people with higher intermediate risk aggressive lymphoma☆, ☆☆, ☆☆☆Abstracted from: Milpied N, Deconinck E, Gaillard F, et al. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 2004;350:1287–95.
Cancer Treatment Reviews. 2004;30(6):577-582   Crossref logo
Link1 Link2

Initial high dose chemotherapy plus autologous stem cell support improves survival outcomes compared with a standard CHOP regimen in people with higher intermediate risk aggressive lymphoma
Cancer Treatment Reviews. 2004;30(6):577-582   Crossref logo
Link1 Link2

Update on High-Dose Adjuvant Chemotherapy and Autologous Stem Cell Rescue in Patients with High-Risk Breast Cancer
Clinical Breast Cancer. 2003;4(3):173-175   Crossref logo
Link1 Link2

High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Rescue for Children with High-Risk Neuroblastoma. Experience of a Single Pediatric Center in Bogotá, Colombia
Biology of Blood and Marrow Transplantation. 2012;18(2):S306   Crossref logo
Link1 Link2

Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma
Pediatric Blood & Cancer. 2014;61(8):1350-1356   Crossref logo
Link1 Link2 Link3

Late effects in high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell rescue
Pediatric Blood & Cancer. 2018;66(1):e27421   Crossref logo
Link1 Link2